ロード中...
High frequency of bladder cancer after nephroureterectomy: justification for adjuvant intravesical treatment?
BACKGROUND: Bladder recurrence after nephroureterectomy (NU) is common. However, there is no acceptable policy of adjuvant intravesical treatment after NU. OBJECTIVE: To assess the rate of bladder recurrence following NU and to identify the high-risk subgroups that may become candidates for adjuvant...
保存先:
| 出版年: | Res Rep Urol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5973432/ https://ncbi.nlm.nih.gov/pubmed/29872646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/RRU.S164166 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|